Skip to main content
OpenTrials
Completed

NCT Number: NCT06363786

Reducing Skin Surface pH During Skin Occlusion: Changes to Skin Microbiome and Skin Parameters

The main aim of this exploratory research study is to investigate how exposure to a material with low pH affects the skin microbiome and skin parameters. This investigation involves an experimental setup in which application of test patches with lowered pH levels or control patches without lowered pH are used. The test patches are applied on healthy adult volunteers. About 20 subjects are planned for the study. The skin microbiome preservation and diversity will be addressed employing Molecular Sequencing and quantitative polymerase chain reaction (qPCR). In addition, skin pH, composition and hydration will be measured with various methods, e.g., AquaFlux, Moisture Meter, TEWL and Confocal Raman spectroscopy. The study will span three consecutive days in total. Each participant will be provided with four patches on each forearm: two patches will be applied to each dorsal forearm and two on each volar forearm. The first day will be for study inclusion and application of patches. In day two the patches will be changed and on day three measurements for pH, TEWL, skin hydration, Raman and tape stripping will be conducted and sampling for Molecular Sequencing and qPCR measurements will be done. There is no formal hypothesis in the study but our idea is that utilizing patches with a lower pH could maintain the diversity and richness of the natural skin microbiome while retaining and even enhancing key skin barrier parameters. A descriptive analysis will be conducted for all measurements with appropriate statistical tests on 5% level for variables. In addition to descriptive data analysis statistics, Clinical Microbiomics and Bio-Me Microbiome Profiling will employ various statistical methods, such as paired Mann-Whitney U tests. The Benjamini-Hochberg (BH) method to control the false discovery rate (FDR) will be employed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Essity Study Site

Gothenburg, SE40503, Sweden

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed Informed Consent Form
  • Male and female ≥18 and ≤80 years.
  • Willingness and ability to comply with study procedures, visit schedules, and requirements.
  • Intact skin on the forearms without any signs of irritation.
  • Agree not to shower or use cosmetic products on the arms the day before visit 1 and during the study period.
  • Agree not to engage in intense physical activity throughout the study period.

Exclusion criteria

  • Have any known allergies or intolerances to one or several components of the absorbing incontinence/menstrual products.
  • Have any known allergies or intolerances to one or several ingredients in cosmetic products.
  • Have an ongoing skin irritation/infection on the forearms.
  • Have any skin conditions such as psoriasis and eczema.
  • Have any tattoos on the forearms.
  • Suffer from excessive sweating, hyperhidrosis.
  • Have immunodeficiency or any other condition that makes participation in the clinical investigation inappropriate, as judged by investigator.
  • Have an alcohol and/or drug dependency.
  • Have had active sunbathing on arms latest 2 weeks prior to study.
  • Have used tanning or bleaching products on arms at least 1 month before the study starts.
  • Have performed hair removal on the arms 1 month prior to the study.
  • Are pregnant or nursing.

Treatment and study plan

Test patches

Other

Patches (incontinence product cut outs) with a low pH formula or control patches without formula.

Primary outcomes

  1. Changes in skin microbiome as measured by molecular sequencing

    Time frame: 2 days

    Molecular sequencing is used to provide taxonomic insight and overview of microbial diversity on the skin. Skin under the test and control patches are compared.

  2. Changes in skin microbiome diversity as measured by qPCR

    Time frame: 2 days

    qPCR is employed to analyse and quantify specific microbial species or groups. Skin under the test and control patches are compared.

  3. Skin surface pH

    Time frame: 2 days

    The change in skin surface pH under the test and control patches are compared.

Secondary outcomes

  1. Change in Trans Epidermal Water loss

    Time frame: 2 days

    As measured by Dermalab instrument. Transepidermal water loss (TEWL) as measured under the test and control patches.

  2. Change in skin hydration

    Time frame: 2 days

    Skin hydration (SH) as measured with moisture meter instrument under the test and control patches.

  3. Change in Skin water profile

    Time frame: 2 days

    As measured Confocal raman microspectrometry. The water content of skin at different depths is measured and compared for the skin under test and control patches.

  4. Presence of low pH formula on the skin

    Time frame: 2 days

    The extent on formula transfer to the skin as measured with tape stripping.

Sponsors and collaborators

Lead sponsor

Essity Hygiene and Health AB

Industry

Registry information

Official study title

Mitigating the Impact of Absorbent Products on Skin Occlusion: Changes to Skin Microbiome and Skin Parameters Due to Reduction of Skin Surface pH in Healthy Participants

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 12, 2024
Registry last updated
Mar 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.